Lbp Am Sa Reduces Stake in Intuitive Surgical, Inc. $ISRG

Lbp Am Sa decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 39.6% during the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 35,422 shares of the medical equipment provider’s stock after selling 23,203 shares during the quarter. Lbp Am Sa’s holdings in Intuitive Surgical were worth $19,249,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Chilton Capital Management LLC increased its position in shares of Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Elite Financial Inc. bought a new stake in Intuitive Surgical during the first quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA purchased a new stake in Intuitive Surgical during the first quarter valued at approximately $30,000. TD Capital Management LLC raised its position in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 45 shares during the period. Finally, 1248 Management LLC bought a new position in Intuitive Surgical in the first quarter worth approximately $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In other news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director directly owned 1,074 shares of the company’s stock, valued at approximately $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 45,224 shares of company stock valued at $21,716,492. Insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on ISRG shares. Wells Fargo & Company upped their price objective on Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 23rd. Zacks Research cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Truist Financial raised their price objective on Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, July 23rd. BTIG Research boosted their price objective on Intuitive Surgical from $566.00 to $571.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. Finally, UBS Group increased their target price on shares of Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a report on Wednesday, July 23rd. Thirteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $595.95.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $447.23 on Wednesday. The firm has a market cap of $160.32 billion, a price-to-earnings ratio of 62.38, a P/E/G ratio of 4.60 and a beta of 1.61. The firm has a fifty day moving average price of $466.61 and a 200 day moving average price of $500.97. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.78 EPS. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.